Ticker Launch
Sign inTry it free

IPO · CV

CapsoVision, Inc

Formerly Capso Vision Inc

CapsoVision, Inc (CV) priced its initial public offering on Jul 3, 2025 at $5.00 per share, within its $5.00–$5.50 range, raising $27.5M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $231.7M. Benchmark was lead-left underwriter, joined by Roth Capital. O’Melveny & Myers advised the company and Ellenoff Grossman & Schole advised the underwriters.

CapsoVision, Inc. is a commercial-stage medical technology company developing imaging and AI technologies for capsule endoscopy to identify gastrointestinal tract abnormalities. Its CapsoCam Plus single-use capsule works with CapsoCloud and CapsoView software.

Status
IPO
Ticker
CV
Exchange
Nasdaq Capital Market
Priced
Jul 3, 2025
IPO price
$5.00
Price range
$5.00–$5.50
Raised
$27.5M
Market cap at IPO price
$231.7M
First filed
May 9, 2025
Underwriters
Benchmark and Roth Capital
Company counsel
O’Melveny & Myers
Underwriters' counsel
Ellenoff Grossman & Schole
Sector
Healthcare
Country / state
CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Healthcare IPOs in 2025